Bayer's Nubeqa drug significantly prolongs survival in prostate cancer trial
Bayer said a therapy mix including its Nubeqa drug was shown to significantly prolong the lives of men suffering from metastatic prostate cancer in a clinical study, underpinning prospects for the... | February 17, 2022
Source: marketscreener.com